 NEW HAVEN, Conn., March 04, 2021 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. BioXcel or the Company Nasdaq: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Thursday, March 11, 2021 at 8:30 AM Eastern Time to discuss its fourth quarter and full year 2020 operating and financial results. 